Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Stephen Oxley acquired 7,407 shares of the business’s stock in a transaction on Wednesday, November 27th. The stock was acquired at an average cost of GBX 1,343 ($16.88) per share, for a total transaction of £99,476.01 ($125,048.41).
Stephen Oxley also recently made the following trade(s):
- On Wednesday, November 20th, Stephen Oxley purchased 24 shares of Johnson Matthey stock. The shares were acquired at an average cost of GBX 1,504 ($18.91) per share, with a total value of £360.96 ($453.75).
- On Friday, October 18th, Stephen Oxley sold 19,554 shares of Johnson Matthey stock. The shares were sold at an average price of GBX 1,526 ($19.18), for a total value of £298,394.04 ($375,102.50).
Johnson Matthey Trading Down 11.7 %
Shares of LON JMAT traded down GBX 175 ($2.20) during mid-day trading on Wednesday, reaching GBX 1,318 ($16.57). 1,926,934 shares of the company’s stock were exchanged, compared to its average volume of 934,067. The company’s 50-day moving average is GBX 1,520.43 and its 200-day moving average is GBX 1,616.82. Johnson Matthey PLC has a 52-week low of GBX 1,318 ($16.57) and a 52-week high of GBX 1,917.07 ($24.10). The company has a debt-to-equity ratio of 63.15, a quick ratio of 0.76 and a current ratio of 1.45. The firm has a market capitalization of £2.30 billion, a price-to-earnings ratio of 2,361.47, a PEG ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey Cuts Dividend
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Articles
- Five stocks we like better than Johnson Matthey
- Investing In Preferred Stock vs. Common Stock
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Calculate Stock Profit
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 REITs to Buy and Hold for the Long Term
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.